AJMC® in the Press, August 23, 2024

Home Health Care Delivery, Outcomes Vary by Payment Model: Rachel A. Prusynski, DPT, PhD

Chimeric antigen receptor T-cell therapies, along with bispecific antibodies, have changed the treatment paradigm for patients with relapsed or refractory mantle cell lymphoma.

November 18th 2025

Global CKD Burden Nearly Doubles Since 1990, Reaching 788 Million Adults Worldwide

Rachel A. Prusynski, DPT, PhD, discusses her study on how payment models affect home health care delivery and patient outcomes.

Listen

Looking ahead, the study called for coordinated international action to address the rising burden of CKD. | Image credit: pyty - stock.adobe.com

Inside the Discovery That Changed CML Treatment Forever with Jorge Cortes, MD

Chronic kidney disease now affects more than 788 million adults globally, with rising prevalence, increasing mortality, and substantial contributions to cardiovascular deaths

November 11th 2025

Genetic Study Establishes Causal Link Between RA and Interstitial Lung Disease Risk

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival.

Listen

Although the study did not stratify risk across patient subgroups, the authors suggest that integrated genetic, serologic, and clinical risk stratification tools could enhance risk prediction. | Image Credit: MicroOne - stock.adobe.com

Ibrutinib-Based Frontline Regimens Narrow the Survival Gap in CLL

A combined assessment of genetic, serologic, and clinical factors may enhance early recognition of patients with RA who are most at risk for ILD.

CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL

Modern ibrutinib-based approaches substantially narrow the traditional survival gap observed in CLL.

Related Content

Home Health Care Delivery, Outcomes Vary by Payment Model: Rachel A. Prusynski, DPT, PhD

Chimeric antigen receptor T-cell therapies, along with bispecific antibodies, have changed the treatment paradigm for patients with relapsed or refractory mantle cell lymphoma.

November 18th 2025

Global CKD Burden Nearly Doubles Since 1990, Reaching 788 Million Adults Worldwide

Rachel A. Prusynski, DPT, PhD, discusses her study on how payment models affect home health care delivery and patient outcomes.

Listen

Inside the Discovery That Changed CML Treatment Forever with Jorge Cortes, MD

Chronic kidney disease now affects more than 788 million adults globally, with rising prevalence, increasing mortality, and substantial contributions to cardiovascular deaths

November 11th 2025

Genetic Study Establishes Causal Link Between RA and Interstitial Lung Disease Risk

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival.

Listen

Ibrutinib-Based Frontline Regimens Narrow the Survival Gap in CLL

A combined assessment of genetic, serologic, and clinical factors may enhance early recognition of patients with RA who are most at risk for ILD.